Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schroeder, J. C.
Right arrow Articles by Weinberg, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schroeder, J. C.
Right arrow Articles by Weinberg, C. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 154, No. 10 : 954-962
Copyright © 2001 by The Johns Hopkins University School of Hygiene and Public Health


ORIGINAL CONTRIBUTIONS

Use of Missing-Data Methods to Correct Bias and Improve Precision in Case-Control Studies in which Cases Are Subtyped but Subtype Information Is Incomplete

Jane C. Schroeder1 and Clarice R. Weinberg2

1 Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC.
2 Biostatistics Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC.

Histologic and genetic markers can sometimes make it possible to refine a disease into subtypes. In a case-control study, an attempt to subcategorize a disease in this way can be important to elucidating its etiology if the subtypes tend to result from distinct causal pathways. Using subtyped case outcomes, one can carry out either a case-case analysis to investigate etiologic heterogeneity or do polytomous logistic regression to estimate odds ratios specific to subtypes. Unfortunately, especially when such an analysis is undertaken after the study has been completed, it may be compromised by the unavailability of tissue specimens, resulting in missing subtype data for many enrolled cases. The authors propose that one can more fully use the available data, including that provided by cases with missing subtype, by using the expectation-maximization algorithm to estimate risk parameters. For illustration, they apply the method to a study of non-Hodgkin's lymphoma in the midwestern United States. The simulations then demonstrate that, under assumptions likely to hold in many settings, the approach eliminates bias that would arise if unclassified cases were ignored and also improves the precision of estimation. Under the same assumptions, empirical confidence interval coverage is consistent with the nominal 95%.

algorithms; bias (epidemiology); case-control studies; computer simulation; epidemiologic methods; logistic models

Abbreviations: EM, expectation-maximization; NHL, non-Hodgkins lymphoma


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. S. Phillips, R. C. Millikan, J. C. Schroeder, J. S. Barnholtz-Sloan, and B. J. Levine
Reproductive and Hormonal Risk Factors for Ductal Carcinoma In situ of the Breast
Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1507 - 1514.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. A. Wark, M. P. Weijenberg, P. van 't Veer, G. van Wijhe, M. Luchtenborg, G. N.P. van Muijen, A. F.P.M. de Goeij, R. A. Goldbohm, and P. A. van den Brandt
Fruits, Vegetables, and hMLH1 Protein-Deficient and -Proficient Colon Cancer: The Netherlands Cohort Study
Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1619 - 1625.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. C. Schroeder, K. Conway, Y. Li, K. Mistry, D. A. Bell, and J. A. Taylor
p53 Mutations in Bladder Cancer: Evidence for Exogenous versus Endogenous Risk Factors
Cancer Res., November 1, 2003; 63(21): 7530 - 7538.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.